KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vertex Pharmaceuticals (VRTX) EPS (Basic): 2009-2024

Historic EPS (Basic) for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Dec 2024 value amounting to -$2.08.

  • Vertex Pharmaceuticals' EPS (Basic) rose 4.69% to $4.24 in Q3 2025 from the same period last year, while for Sep 2025 it was $14.31, marking a year-over-year increase of 873.51%. This contributed to the annual value of -$2.08 for FY2024, which is 114.80% down from last year.
  • Per Vertex Pharmaceuticals' latest filing, its EPS (Basic) stood at -$2.08 for FY2024, which was down 114.80% from $14.05 recorded in FY2023.
  • In the past 5 years, Vertex Pharmaceuticals' EPS (Basic) ranged from a high of $14.05 in FY2023 and a low of -$2.08 during FY2024.
  • In the last 3 years, Vertex Pharmaceuticals' EPS (Basic) had a median value of $12.97 in 2022 and averaged $8.31.
  • Per our database at Business Quant, Vertex Pharmaceuticals' EPS (Basic) skyrocketed by 127.95% in 2020 and then slumped by 114.80% in 2024.
  • Yearly analysis of 5 years shows Vertex Pharmaceuticals' EPS (Basic) stood at $10.44 in 2020, then declined by 12.93% to $9.09 in 2021, then soared by 42.68% to $12.97 in 2022, then climbed by 8.33% to $14.05 in 2023, then tumbled by 114.80% to -$2.08 in 2024.